Long-term Ocular Safety in Children Treated with Mitogen-Activated Protein Kinase Pathway Inhibitor Therapy

Ophthalmology. 2026 Feb;133(2):291-294. doi: 10.1016/j.ophtha.2025.09.031. Epub 2025 Oct 10.
No abstract available

Keywords: MEK inhibitor-associated retinopathy; Mitogen-activated protein kinase kinase pathway inhibitors; Neurofibromatosis 1; Selumetinib.